Auspharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -206235.59%
- Net Worth -243.76%
- Total Assets 17354.85%
About Auspharma
Auspharma Private Limited (APL) is a Private Limited Indian Non-Government Company incorporated in India on 22 August 2020 (Four years and five months 10 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arvind Venkat and Narasaiah Arigela serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24304TG2020PTC143079
- Company No.
143079
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Aug 2020
- Date of AGM
20 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Auspharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvind Venkat  | Director | 22-Aug-2020 | Current |
| Narasaiah Arigela | Director | 22-Aug-2020 | Current |
Financial Performance of Auspharma.
Auspharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 206235.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 243.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Auspharma?
In 2021, Auspharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indian Hospitex Private LimitedNarasaiah Arigela is a mutual person
Keimed Private LimitedArvind Venkat is a mutual person
Neelkanth Drugs Private LimitedArvind Venkat is a mutual person
Prime Time Logistics Technologies Private LimitedArvind Venkat and Narasaiah Arigela are mutual person
- New Viswabharathy Drug Lines Private Limited
Narasaiah Arigela is a mutual person
- Guninaa Pharmaceuticals Private Limited
Narasaiah Arigela is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Auspharma?
Auspharma has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Auspharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Auspharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.